Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Aurinia Pharma Skyrockets on Positive Data From Lupus Study Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) has been on a meteoric rise over the past month. In this time the stock has gained over 150%, on what has been relatively little news for such a massive move. However shares saw a gain of more than 30% on Thursday over positive data from the company’s Aurion study. It is an exploratory study being conducted in multiple sites in Malaysia to assess the short-term predictors of response using voclosporin in combination with mycophenolate mofetil and oral corticosteroids in patients with active lupus nephritis. http://247wallst.com/healthcare-bus...skyrockets-on-positive-data-from-lupus-study/
Aurinia Pharmaceuticals ($AUPH) is moving notably higher in pre-market trading after the biopharmaceutical company announced developments plans for its active lupus nephritis treatment in Europe and Japan.
I want to see a move to $8 if possible, but even if this does not run higher today, this is a pretty solid company, just need that support to keep holding.
Just curious how many shares you guys are holding. I'm sub 1000, but will be picking up a part-time job to supplement my investments.
How many shares somebody holds has more to do with their risk tolerance and overall financial situation. A multi-millionaire holding 1000 shares is very different from a starving student holding 1000 shares.
^^ don't like Cramer but he is pumping AUPH on madmoney tonight so shorting now = risky ? https://twitter.com/MadMoneyOnCNBC?ref_src=twsrc^google|twcamp^serp|twgr^author
Ignore the noise. Still trading sideways. Patience is a must with AUPH. Scared money will regret in 9 months.
AUPH has been performing very well in the recent market downturn, its pulling back today, so if anybody was watching for an entry...